CombiGene participated in a positive meeting with the European Medicines Agency

All development of new and unique therapies for humans and animals requires close
cooperation with the public agencies that make the final decision on product approval.


“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”